Navigation Links
Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
Date:11/18/2009

PITTSBURGH, Nov. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Didier Barret, president of Mylan Europe, Middle East and Africa (EMEA), has been elected president of the European Generic Medicines Association (EGA). Barret was elected to a two-year term earlier today at the EGA annual meeting being held in Brussels.

Mylan Chairman and CEO Robert J. Coury said: "We are extremely pleased to have one of our own senior executives lead Europe's generic trade organization over the next two years. The EGA could not have elected a stronger leader to help guide our industry in Europe than Didier Barret. His willingness to serve EGA in this capacity emphasizes Mylan's commitment to enhance industry efforts in international markets as generic pharmaceuticals represent a proven and successful solution to rising global health care costs."

Commenting on his appointment Barret said: "I am very proud to be able to serve EGA as president. One of my goals is to replicate the kind of strong collaboration that Mylan has had with the industry associations across the world. I also look forward to continuing to help shape the European generics marketplace as a facilitator between the industry and our colleagues at health care agencies across the different European regions. Creating conditions for a sustainable and competitive generics industry within the European market will be a priority for EGA in the years ahead."

The EGA is the official representative body of the European generic and bio-similar pharmaceutical industry, which is at the forefront of providing high quality affordable medicines to millions of Europeans and stimulating competitiveness and innovation in the pharmaceutical sector. Formed in 1993, the EGA represents generic pharmaceuticals companies and their subsidiaries throughout Europe, either directly or through national associations.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.

SOURCE Mylan Inc.


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lexington International, LLC Receives 2009 U.S. Presidents E Award Recognizing its Export Achievements
2. IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
3. Voler Systems President Speaks at BIOMEDevice San Jose
4. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
5. Gary Wenzel Named President TBWA\WorldHealth
6. Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
7. VIVUS Announces Promotion of Peter Tam to President
8. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
9. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
10. ClinOps, LLC Enhances Senior Management Team With Addition of Connie Andrews as Senior Vice President of Clinical Operations
11. Csuy Named Senior Vice President/General Merchandise Manager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):